• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
European Antidepressants Markets Product Image

European Antidepressants Markets

  • Published: June 2006
  • Region: Europe
  • Frost & Sullivan

This Frost & Sullivan research service titled European Antidepressants Markets provides a detailed analysis of the antidepressants markets, with a description of key market drivers and restraints. An analysis of the product pipelines of leading companies as well as overall market forecasts are also provided. In this research, Frost & Sullivan’s expert analysts thoroughly examine the following markets: selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and other antidepressants.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
- Selective serotonin reuptake inhibitors (SSRIs)
- Serotonin-norepinephrine reuptake inhibitors (SNRIs)
- Other antidepressants

Market Overview

Better Efficacy and Relatively Lesser Side-effects of SNRIs to Promote Continued Market Growth

The increasing incidence of depression and anxiety disorders in Europe is leading to greater focus on diagnosis and treatment options, thus contributing to the significance of antidepressants. Apart from this, antidepressants are being investigated READ MORE >

1. Executive Summary
1. Introduction to the European Antidepressants Market
1. Summary of the European Antidepressants Market 2. Glossary of Terms and Research Methodology
1. List of Terms
1. Abbreviations
2. Research Methodology
1. Methodology of Research for the European Antidepressants Market 3. Industry Challenges
1. Challenges and Issues
1. Challenges Facing the European Antidepressants Market 4. Market Engineering Research of the European Antidepressants Market
1. Forecasts of the Overall Market
1. Overview of Depression and Related Disorders
2. Disease Burden
3. Disease Prevalence
4. Market Engineering Measurements
5. Factors Driving the European Antidepressants Market
6. Factors Restraining the European Antidepressants Market
7. Revenue Forecasts
8. Trends by Geography
9. Trends by Segment
10. Competitive Structure
11. Market Share Analysis 5. Segment-wise Forecasts
1. Forecasts of the Selective Serotonin Reuptake Inhibitor (SSRI) Market
1. Introduction to SSRIs
2. Market Engineering Measurements
3. Revenue Forecasts
2. Forecasts of the Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) Market
1. Introduction to SNRIs
2. Market Engineering Measurements
3. Revenue Forecasts
3. Forecasts of the Other Antidepressant Market
1. Introduction to Other Antidepressants
2. Market Engineering Measurements
3. Revenue Forecasts 6. Opportunities by Geography
1. The United Kingdom Antidepressants Market
1. Market Overview
2. Trends and Issues
2. The German Antidepressants Market
1. Market Overview
2. Trends and Issues
3. The French Antidepressants Market
1. Market Overview
2. Trends and Issues
4. The Spanish Antidepressants Market
1. Market Overview
2. Trends and Issues
5. The Italian Antidepressants Market
1. Market Overview
2. Trends and Issues
6. The Benelux Antidepressants Market
1. Market Overview
2. Trends and Issues
7. The Scandinavian Antidepressants Market
1. Market Overview
2. Trends and Issues 7. Product Analysis
1. Analysis of Key Antidepressants in the European Market
1. Prozac
2. Zoloft
3. Paxil
4. Citalopram
5. Cipralex
6. Wellbutrin
7. Effexor
2. Analysis of Potential Blockbuster Antidepressants
1. Cymbalta
2. Saredutant
3. DVS-233 8. Antidepressant Pipeline Analysis
1. Antidepressants in the Pipeline
1. Glaxosmithkline
2. Lundbeck
3. Sanofi-Aventis
4. Astrazeneca
5. Wyeth 9. Strategic Recommendations
1. Recommendations for the European Antidepressant Market Participants
1. Strategies for the European Antidepressants Market 10. Frost &amp
Sullivan Awards for the Antidepressants Market
1. Frost &amp
Sullivan Awards
1. Frost &amp
Sullivan Awards
2. Product Differentiation Innovation Award
3. Growth Strategy Leadership Award 11. Database of Key Industry Participants (DKIP)
1. List of Key Industry Participants
1. Database of Key Market Participants 12. Decision Support Databases (DSDs)
1. DSD Tables
1. Number of Psychiatry Beds
2. Prevalence of Urinary Incontinence
List of Figures

Chapter 3
.

Antidepressants Market: Impact of Top Industry Challenges (Europe), 2006-2012

Chapter 4
.

Antidepressants Market: Market Drivers Ranked in Order of Impact (Europe), 2006-2012

Antidepressants Market: Market Restraints Ranked in Order of Impact (Europe), 2006-2012

Antidepressants Market: Revenue Forecasts (Europe), 2002-2012

Antidepressants Market: Per Cent of Revenues by Geographic Region (Europe), 2005

Antidepressants Market: Per Cent of Revenues by Segment (Europe), 2002-2012

Antidepressants Market: Competitive Structure (Europe), 2005

Antidepressants Market: Market Share and Growth Rate of Leading Products (Europe), 2005

Chapter 5
.

Selective Serotonin Reuptake Inhibitors (SSRIs) Market: Revenue Forecasts (Europe), 2002-2012

Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) Market: Revenue Forecasts (Europe), 2002-2012

Other Antidepressants Market: Revenue Forecasts (Europe), 2002-2012

Chapter 12
.

Decision Support Database: Number of Beds in Psychiatric Hospitals in 000 (World), 1999-2006

Decision Support Database: Prevalence of Urinary Incontinence in Million (World), 1999-2006

|

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos